Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Huss

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|August 21, 2013
Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosisLinda Hammerich, Jörg M Bangen, Olivier Govaere, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
Urologic Oncology|May 5, 2019
Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experienceLars Henning Schmidt, Sebastian Huss, Christoph Schuelke, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 4, 2012
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytesAlexandra Wojtalla, Frank Herweck, Michaela Granzow, et al.
The American Journal of Pathology|October 28, 2015
Endogenous Il10 alleviates the systemic antiviral cellular immune response and T cell-mediated immunopathology in select organs of acutely LCMV-infected miceKristin Jakobshagen, Beate Ward, Nikola Baschuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
Oncotarget|September 24, 2016
MDM2 and CDK4 amplifications are rare events in salivary duct carcinomasInga Grünewald, Marcel Trautmann, Alina Busch, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|August 21, 2013
Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosisLinda Hammerich, Jörg M Bangen, Olivier Govaere, et al.
Molecular Cancer Therapeutics|February 22, 2019
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid LiposarcomaMarcel Trautmann, Magdalene Cyra, Ilka Isfort, et al.
Urologic Oncology|May 5, 2019
Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experienceLars Henning Schmidt, Sebastian Huss, Christoph Schuelke, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 4, 2012
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytesAlexandra Wojtalla, Frank Herweck, Michaela Granzow, et al.
The American Journal of Pathology|October 28, 2015
Endogenous Il10 alleviates the systemic antiviral cellular immune response and T cell-mediated immunopathology in select organs of acutely LCMV-infected miceKristin Jakobshagen, Beate Ward, Nikola Baschuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
Oncotarget|September 24, 2016
MDM2 and CDK4 amplifications are rare events in salivary duct carcinomasInga Grünewald, Marcel Trautmann, Alina Busch, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Pageof 8